Jpmorgan Chase & CO Guardant Health, Inc. Transaction History

Jpmorgan Chase & CO

$1.14 Trillion
Q2 2024

A detailed history of Jpmorgan Chase & CO transactions in Guardant Health, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 429,385 shares of GH stock, worth $10.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

429,385

Previous 160,251 167.95%

Holding current value

$10.1 Million

Previous $3.31 Million 275.19%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$16.07 - $31.84 $4.32 Million - $8.57 Million	269,134 Added 167.95%	429,385 $12.4 Million
Q1 2024 May 10, 2024	SELL	$17.13 - $26.91 $5.53 Million - $8.68 Million	-322,562 Reduced 66.81%	160,251 $3.31 Million
Q4 2023 Feb 12, 2024	BUY	$21.58 - $29.5 $1.28 Million - $1.74 Million	59,090 Added 13.95%	482,813 $13.1 Million
Q3 2023 Nov 14, 2023	SELL	$25.8 - $39.97 $6.82 Million - $10.6 Million	-264,227 Reduced 38.41%	423,723 $12.6 Million
Q2 2023 Aug 11, 2023	BUY	$20.94 - $38.01 $939,221 - $1.7 Million	44,853 Added 6.97%	687,950 $24.6 Million
Q1 2023 May 18, 2023	BUY	$22.92 - $33.76 $1.31 Million - $1.93 Million	57,266 Added 9.78%	643,097 $15.1 Million
Q1 2023 May 11, 2023	BUY	$22.92 - $33.76 $9.19 Million - $13.5 Million	400,775 Added 216.57%	585,831 $13.7 Million
Q4 2022 Feb 13, 2023	SELL	$25.44 - $59.78 $20.7 Million - $48.6 Million	-812,649 Reduced 81.45%	185,056 $5.03 Million
Q3 2022 Nov 14, 2022	BUY	$43.66 - $61.0 $35.9 Million - $50.2 Million	822,954 Added 470.93%	997,705 $53.7 Million
Q2 2022 Aug 11, 2022	SELL	$28.82 - $77.35 $441,320 - $1.18 Million	-15,313 Reduced 8.06%	174,751 $7.05 Million
Q1 2022 May 11, 2022	SELL	$48.25 - $100.49 $2.49 Million - $5.19 Million	-51,601 Reduced 21.35%	190,064 $12.6 Million
Q4 2021 Feb 10, 2022	BUY	$88.71 - $120.43 $11.1 Million - $15.1 Million	125,082 Added 107.29%	241,665 $24.2 Million
Q3 2021 Nov 12, 2021	BUY	$98.77 - $132.17 $11.5 Million - $15.4 Million	116,583 New	116,583 $14.6 Million

Others Institutions Holding GH

# of Institutions

331

Shares Held

113M

Call Options Held

680K

Put Options Held

1.67M

View Full List

About Guardant Health, Inc.

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $2.41B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

More about GH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Guardant Health, Inc. Transaction History